bannter.jpg

 

Citation: Yiğit M, Günes A, Uğuz C, Yalcin TO, Tök L, Öz A, Nazıroğlu M. Effects of astaxanthin on antioxidant parameters in ARPE-19 cells on oxidative stress model. Int J Ophthalmol 2019;12(6):930-935

DOI:10.18240/ijo.2019.06.08

·Basic Research·

 

Effects of astaxanthin on antioxidant parameters in ARPE-19 cells on oxidative stress model

 

Yiğit Musa1, Güneş Alime1, Uğuz Cihangir2, Yalçın Tök Özlem1, Tök Levent1, Öz Ahmi2, Nazıroğlu Mustafa2

 

1Department of Ophthalmology, Süleyman Demirel University Research and Education Hospital, Çünür-Isparta 32200, Turkey

2Department of Biophysics, Faculty of Medicine, Süleyman Demirel University Research and Education Hospital, Çünür-Isparta 32200, Turkey

Correspondence to: Yiğit Musa. Department of Ophthalmology, Süleyman Demirel University Research and Education Hospital, Çünür-Isparta 32200, Turkey. myigit15@gmail.com

Received: 2018-04-07        Accepted: 2019-04-19

 

Abstract

AIM: To observe the protective effect of astaxanthin (AST) against hydroquinone (HQ) mediated cell death in the apoptotic cascade and evaluate intracellular Ca2+ release, caspase-3, and -9 activation, reactive oxygen species (ROS) production in ARPE-19 cells.

METHODS: We cultured ARPE-19 cells in special mediums and performed MTT tests to determine protective effect of AST, before exposing the cells to HQ in an incubator. We analyzed intracellular Ca2+ release experiments, mitochondrial membrane depolarization, glutathione (GSH), glutathione peroxidase (GSH-Px) and ROS experiments, and apoptosis assay.

RESULTS: ROS production ranges depend on the amount of cell death. We computed the correlation between ROS ranges and cell death by 20,70-dichlorofluorescein fluorescence, and Ca2+ levels by Fura-2-AM. HQ-induced cell death found out to rise ranges of caspase-3 and -9, and mitochondrial depolarization. These three steps were delayed by AST management.

CONCLUSION: ARPE-19 cells are avoided from HQ-induced ROS production and caspase-3 and -9 activation by AST. AST may limit the range of caspase synthesis, Ca2+ release and excess production of ROS with antiapoptotic effect. This study proposes a new therapeutic approach for the treatment of age-related macular degeneration.

KEYWORDS: apoptosis; ARPE-19 cell; astaxanthin; oxidative stress

DOI:10.18240/ijo.2019.06.08

 

Citation: Yiğit M, Günes A, Uğuz C, Yalcin TO, Tök L, Öz A, Nazıroğlu M. Effects of astaxanthin on antioxidant parameters in ARPE-19 cells on oxidative stress model. Int J Ophthalmol 2019;12(6):930-935


Outline

INTRODUCTION

SUBJECTS AND METHODS

RESULTS

DISCUSSION

ACKNOWLEDGEMENTS

REFERENCES

 

INTRODUCTION

Age-related macular degeneration (AMD) is the most important reason of irreversible vision loss in aged people in the world and it is also a severe, progressive ophthalmologic problem[1-2]. There are some risk factors of AMD development and progression like advanced age, Caucasian race, genetic polymorphisms, high body mass index, excess alcohol consumption and smoking history[3-4]. Today, the pathogenesis of AMD is not known exactly, but oxidative stress play an important role in the pathogenesis. Retina pigment epithelial (RPE) cell degeneration occurred frequently in early stages of the disease, may enlarge in macular region in progress of time[5-6].

Cigarette smoking enhances the formation of oxidative damage in the body and weakens the antioxidant defense mechanisms with age, may lead to increased inflammation. Some studies report that smoking is one of the major risk factors associated with the prevalence and incidence of AMD. Hydroquinone (HQ) is found not only in cigarettes but also in processed foods, in plastic containers, in the atmosphere, namely that is widely present in nature. HQ present in high concentrations in cigarettes. It is an aromatic organic phenol compound and also known as benzene-14-diol or quinol, may return to parabenzoquinone (C6H6O2) by oxidation[7-14].

Astaxanthin (AST) is an antioxidant molecule found in high amounts in shellfish known as non-provitamin xanthophyl carotenoid[15]. Recently, AST, for antioxidant effect, is added to the nutritional supplements used in AMD patients[16]. However, it is not known exactly about the protective activity of AST against oxidative stress generated by cigarettes on RPE cells.

Homeostasis of intracellular calcium concentration ([Ca2+]i) is important for cellular signaling mechanisms because of managing cellular functions like protein synthesis, gene expression, etc. The [Ca2+]i may exchange by the cell membranes and releasing from the intracellular calcium stores through specialized calcium channels. By this way cytosolic Ca2+ stability is regulated[5]. On the other hand Ca2+ has proapoptotic effects which are mediated by a multifarious level of Ca2+-sensitive factors that are seperated in several intracellular organelle[6]. That’s why free [Ca2+]i increases after cation channel function  degeneration by oxidative stress, physiologic capacities of cells may be lost at the end[8-9]. Accumulation of Ca2+ in the cytosol may lead to stimulate the apoptosis-promoting factors releasing. Some reports indicate that oxidative stress induced dysregulated [Ca2+]i stability is accompanied by alterations in the apoptotic activity of diverse cell types.

In this study, our goal was to observe the protective capacity and ability of AST against the HQ-caused oxidative stress on in vitro RPE cells. And also we aimed to observe the role of oxidation caused by cigarette smoking in the AMD disease and then to be able to stop or treat the degeneration by using AST.


SUBJECTS AND METHODS

Chemicals  All organic solvents were purchased from Merck (Darmstadt, Germany). Buffers and other cehemicals; the hydrogen hydroperoxide (H2O2), potassium hydroxide, sodium hydroxide, 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate hydrate (CHAPS), thiobarbituric acid (TBA), 1,1,3,3-tetraethoxypropane (TEP), 5,5-dithiobis-2 nitrobenzoic acid (DTNB), tris(hydroxymethyl)aminomethane, reduced glutathione (GSH), butylhydroxytoluene, Triton X-100, and ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA) were obtained from Sigma-Aldrich (St Louis, MO, USA). The fluorescein dye fura-2 acetoxymethyl ester (Fura-2) was purchased from Invitrogen (Carlsbad, CA, USA). All reagents were of analytical grade and were prepared daily and stored at +4 except the phosphate buffers. Reagents were equilibrated at room temperature for half an hour before an analysis was initiated or reagent containers were refilled. Phosphate buffers were stable at +4 for 1mo. APOPercentage Assay Kit was purchased from Biocolor (Belfast, Northern Ireland, UK).

Study Groups  Group I was the control, the cells were incubated during 24h in its special growth medium. Group II was HQ group, the cells were incubated with 100 µmol/L HQ for 24h. Group III was AST group, the cells were incubated with 200 µmol/L AST for 24h. Group IV was HQ+AST group and the cells were incubated with 100 µmol/L HQ during first 24h, and then incubated with 200 µmol/L AST during second 24h.

Cell Culture  The human retinal pigmented epithelial cell line (ARPE-19; ATCC, Manassas, VA, USA) was grown in a special mixture of a growth medium containing 1:1 ratio of DMEM and Ham’s F12 medium supplemented with 10% fetal bovine serum (FBS; Biochrom, Berlin, Germany) and 1% penicillin-streptomycin combination (Biochrom). Cells were used for the experiments at passages 3-10.

Calcium [Ca2+]i Determination by Fluorescent Dye  After all incubation processes, cells were loaded with 4 µmol/L Fura-2 acetoxymethyl ester (Carlsbad, CA, USA) dye by incubation for 30min at room temperature according to a procedure published elsewhere[7]. Then the cells were washed and gently re-suspended in Na-HEPES buffer solution containing (in mmol/L): NaCl, 140; KCl, 4.7; CaCl2, 1.2; MgCl2, 1.1; D-glucose, 10; and HEPES, 10 (pH 7.4). The cells in all groups were exposed to H2O2 to stimulate [Ca2+]i release. Fluorescence signals were recorded from 2 mL aliquots (2×106 cells/mL) at 37 using a spectrofluorometer (Cary Eclipse, Varian Inc., Sydney, Australia) with excitation wavelengths at 340 nm and 380 nm, and emission at 505 nm. The [Ca2+]i oscillations were determined by using the 340/380 nm fluorescence ratio and were calibrated according to the method of Grynkiewicz et al[12]. Ca2+ release was evaluated using the integral of the rise in [Ca2+]i for 60s after addition of H2O2. The Ca2+ release is expressed as nmol/L, taking a sample every second (nmol/L/s) as described elsewhere [11].

Measurement of Lipid Peroxidation Level  The lipid peroxidation levels in all groups were measured with TBA reaction method by Placer et al[16]. The quantification of TBA-reactive substances was determined by comparing the absorption to the standard curve of MDA equivalents generated by acid catalyzed hydrolysis of 1,1,3,3-tetraethoxypropane.

Reduced Glutathione, Glutathione Peroxidase, and Protein Assays  The GSH content of all groups was measured at 412 nm by using the Sedlak and Lindsay method[17]. The glutathione peroxidase (GSH-Px) activities of groups were spectrophotometrically measured at 37 and 412 nm according to the Lawrence and Burk method[18]. The protein content in all groups was determined by Lowry et al’s method[19] with bovine serum albumin regarded as the standard.

Measurement of Mitochondrial Membrane Potential  In order to measurement of mitochondrial membrane potential, all groups were loaded with 1 µmol/L tetraethylbenzimidazolylcarbocyanine iodide (JC-1) for 15min at 37 as previously described[20]. The cationic dye JC-1 indicates intermembrane potential-dependent aggregation in mitochondria that shows mitochondrial depolarization by a decrease in the red-to-green fluorescence intensity ratio. After incubation the dye was removed, and the cells were washed with 1× phosphate buffered saline (PBS). The green JC-1 signal was recorded at 485 nm excitation wavelength and 535 nm emission wavelength. And for the red signal, at the excitation wavelength of 540 nm and the emission wavelength of 590 nm were used respectively. Fluorescence changes were screened using a fluorescence microplate reader (Tecan Infinite 200 Pro, Austria). The results are presented as emission ratios (590/535). Changing in the mitochondrial membrane potential was quantified as the integral of the decrease in JC-1 fluorescence ratio.

Apoptosis Assay  For the assessment of rational apoptosis, the APOPercentage Assay Kit was purchased by Biocolor Ltd., Belfast, UK. The kit was performed according to the manufacturer’s instructions. In brief, the kit content is a dye-uptake assay, which stains only the apoptotic cells with a red color. When the plasma membrane asymmetry lost, the APOPercentage dye is actively entered into cells, stains only apoptotic cells into red and thus allows detection of apoptosis by spectrophotometer[21].

Assay for Caspase Activities  After incubations the cells were sonicated and lysates were incubated with 2 mL of substrate solution [20 mmol/L HEPES (pH 7.4), 2 mmol/L EDTA, 0.1% CHAPS, 5 mmol/L DTT and 8.25 µmol/L of caspase substrate] for 1h at 37, as previously described[22]. Caspase-3 and -9 were calculated by the cleavage of the specific indicator fluorogenic substrates (AC-DEVD-AMC for caspase-3 and AC-LEHD-AMC for caspase-9). The substrate cleavage was measured with a fluorescence spectrophotometer at 360 nm excitation wavelength and at 460 nm emission wavelength. At the presence of inhibitors of caspase-3 or -9, DEVD-CMK or z-LEHD-FMK, respectively, cleaving of substrates were not detected. The data were calculated as fluorescence units per milligram of protein.

Statistical Analysis  Data are expressed as means±SEM of the number of determinations. Statistical significance was analysed by using the SPSS packet program (9.05, SPSS, Chicago, IL, USA). To compare the effects of different treatments, statistical significance was calculated by Mann-Whitney U test. P<0.05 was considered to indicate a statistically significant difference.


RESULTS

Effects of Astaxanthin on Intracellular Ca2+ Release in ARPE-19 Cells  Intracellular Ca2+ levels; there is a significant increase with HQ (P<0.001); decrease with AST (P<0.001) as shown in Figure 1A and 1B, with a significant additive effect: [Ca2+]i levels were significantly lower in group AST group compared with the other groups (P<0.05).

Yigit Musa1

Figure 1 The effects of hydroquinone and astaxanthin on the release of Ca²+ in the cytosol in the ARPE-19 cell groups  A: Time-flow chart of the Ca²+ release in the cytosol in the ARPE-19 cell groups of hydroquinone and astaxanthin. The cells were loaded with Fura-2-AM over 45min in a shaking water bath. The cells were stimulated with H2O2. Original time-course chart recordings showing cytosolic Ca2+ ([Ca2+]i) transients in ARPE-19 cells; B: Bar charts showing mean±SD data for the cytosolic [Ca2+]i concentration from H2O2-stimulated ARPE-19 cells (n=6 for each). aP<0.05 vs Control; bP<0.05 vs AST; cP<0.001 vs HQ.

 

Effects of Astaxanthin on Lipid Peroxidation, Glutathione, and Glutathione Peroxidase Ranges  The effects of AST on the balance of [Ca2+]i after HQ implementation correlate with increase in lipid peroxidation as indicated by the increase in MDA, intracellular GSH-Px levels and reduction in GSH (Table 1). However, AST supplementations were associated to an increase in GSH levels compared with other groups, and decreased MDA levels (Table 1).

Table 1 Effects of AST, HQ, and their combinations on LP, GSH-Px, GSH           mean±SD

Parameters/Groups

Control

HQ

AST

HQ+AST

LP (μmol/5×106 cells)

8.79±0.46

9.82±0.63a

8.45±0.31b

8.60±0.81b

GSH (μmol/5×106 cells)

6.94±0.82

5.25±0.85a

8.34±1.12a,b

7.49±0.46a,b,c

GSH-Px (IU/5×106 cells)

5.62±0.67

4.68±0.74a

7.15±0.33a,b

6.25±0.93a,b,c

AST: Astaxanthin; HQ: Hydroquinone; LP: Lipid peroxidation; GSH-Px: Glutathione peroxidase; GSH: Glutathione. aP<0.05 vs Control; bP<0.05 vs HQ; cP<0.05 vs AST.

 

Effects of Astaxanthin on Mitochondrial Depolarization Levels  The effects of AST on mitochondrial depolarization levels in ARPE-19 cells was shown in Figure 2. AST administration significantly decreased hidroquinone triggerred mitochondrial depolarization levels. There was a significant reduction in mitochondrial depolarization levels after AST supplementation according to the other groups (P<0.05).

Yigit Musa2

Figure 2 The effects of astaxanthin on mitochondrial depolarization levels in ARPE-19 cells  The ARPE-19 cells showed significantly altered mitochondrial membrane depolarization levels after treatment with HQ (P<0.05). The mitochondrial depolarization levels in the astaxanthin group significantly decreased when compared with those in the HQ and the control group. However, astaxanthin has the ability to decrease the increased mitochondrial depolarization levels in the HQ group. aP<0.05 vs Control; bP<0.05 vs HQ; cP<0.05 vs AST.

 

Effects of Astaxanthin on Apoptosis, Caspase- 3, and -9 Levels  The effects of AST on apoptosis levels, caspase-3 and -9 levels after HQ implementation were shown in Figures 3, 4, respectively. By itself, AST decreased the apoptosis significantly (P<0.05). Caspase-3 and -9 levels were also decreased in a manner relating with apoptosis levels.

Yigit Musa3

Figure 3 The effects of astaxanthin and hydroquinone on apoptosis levels in ARPE-19 cells  The ARPE-19 cells showed significantly increased apoptosis levels after treatment with HQ. AST incubation significantly decreased apoptosis levels. aP<0.05 vs Control; bP<0.05 vs HQ; cP<0.05 vs AST.

Yigit Musa4

Figure 4 The ARPE-19 cells showed significantly increased caspase-3/-9 (A and B respectively) activity levels after treatment with HQ  The caspase-3/-9 levels in the AST group did not show any significant changes when compared to control group. aP<0.05 vs Control; bP<0.05 vs HQ; cP<0.05 vs AST.

 

DISCUSSION

AMD is one of the main reason of vision loss in those over age 50 in developed nations[23]. In smokers increased oxidative stress with age is an important reason for the development of AMD. This paves the way for a progressive degeneration of the RPE and photoreceptor cells in the macula[22,24]. As a result of increased oxidative stress in AMD with cigarette smoking, RPE degeneration occurs and apoptosis in ocular cells are triggered[25-26].

AST is a red pigment that belongs to carotenoid family and found at high levels in shellfish[20]. Some studies report that AST is a powerful antioxidant and neutralize the reactive radical products. Also AST can cross the blood-brain barrier by transcytosis[27-28]. In addition to the immunomodulator activity of AST has some biological protector activity for islet β-cells in the pancreas and liver, hypertension and ischemia-induced amnesia. Animal studies define that AST prevents the lens damage caused by oxidative stress and Ca2+[29-32].

Healthy lens contains GSH at high amounts which has antioxidant properties, therefore it is fundamental to  retain tissue transparency for clear vision[33]. Decreasesing activity of GSH in old lenses with age, giving rise to oxidation. Zeaxanthin and lutein are the two macular carotenoids which are important for protection from AMD and they are acting on intracellular GSH levels. Moreover, AST has been determined to have ten times higher antioxidant activity than lutein, canthaxanthin, β-carotene and hundred times higher than α-tocopherol[34-35]. Today, oral intake of zeaxanthin and lutein are recommended for AMD patients[36]. Wu et al[37] defined that a high intake of bioavailable zeaxanthin and lutein is associated with long-term decreased risk of dry/atrophic AMD in individuals aged 50y or older.

Our study is important because it is the first molecular study evaluating the effects of AST to intracellular Ca2+ levels in ARPE-19 cells. Statistically, AST decreased significantly intracellular Ca2+ release in ARPE-19 cells. In the HQ group not incubated by AST, intracellular Ca2+ release levels are determined at the maximum amounts. We can easily say that these effects of AST are because of its antioxidant properties. However, due to the limited isomerization and biological activity of AST in humans, astaxanthin is suggested to be useful in the dietary support for AMD patients.

Oxidative stress is a chain of reactions which can occur even in normal physiological processes and reaction products return to the oxidizing agents. Superoxide radicals, hydrogen peroxide, hydroxyl radicals, peroxynitrite, etc. are the main mediators of oxidising agents.

Mitochondria are the first target of reactive oxygen species and exposed to the greatest damage. Excessive reactive oxygen species (ROS) triggers programmed cell death in cells called apoptosis. As a result of incubation with AST, we found that the statistically significant decrease in ROS levels. Whether buffering systems for increased amount of intracelluler Ca2+ are insufficient, apoptosis may occur[38-40].

We observed that, incubation with AST leads significant reduction in amount of apoptosis, caspase-3, caspase-9 and ROS levels when compared with HQ group samples.

The clinical aspects of our findings was supported by different studies previously. Piermarocchi et al[41] determined that AST intake might have a key role in preventing of AMD.

Moreover, in an animal experiment, Izumi-Nagaki et al[42] determined that, AST treatment, suppressed inflammatory processes including subsequent upregulation of inflammatory molecules, macrophage infiltration, and NF-kappa B activation, which significantly suppress choroidal neovascularization (CNV) development.

Similar to this study, Nakajima et al[43] also demonstrated the protective role of AST against oxidative stress model in mice model.

In conclusion, AST’s biochemical activities are not yet fully revealed. Our study’s aim is to determine the protective effect of AST against oxidative stress in ARPE-19 cells. Hence the AST intake can be used in the treatment of AMD, caused by oxidative stress as the primary factor. AST may reduce or stop the progression of macular degeneration and it may even be that recovery according to the intensity of disease. However, detailed studies may be needed to keep track of more effective treatment.


ACKNOWLEDGEMENTS

Conflicts of Interest: Yiğit M, None; Günes A, None; Uğuz C, None; Yalcin TO, None; Tök L, None; Öz A, None; Nazıroğlu M, None.


REFERENCES

1 Reiter RJ, Tan DX. Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res 2003;58(1):10-19.
https://doi.org/10.1016/S0008-6363(02)00827-1

 

2 Yan Q, Ding Y, Liu Y, Sun T, Fritsche LG, Clemons T, Ratnapriya R, Klein ML, Cook RJ, Liu Y, Fan RZ, Wei L, Abecasis GR, Swaroop A, Chew EY, AREDS Research Group, Weeks DE, Chen W. Genome-wide analysis of disease progression in age-related macular degeneration. Hum Mol Genet 2018;27(5):929-940.
https://doi.org/10.1093/hmg/ddy002
PMid:29346644 PMCid:PMC6059197

 

3 Ivanova TN, Alonso-Gomez AL, Iuvone PM. Dopamine D4 receptors regulate intracellular calcium concentration in cultured chicken cone photoreceptor cells: relationship to dopamine receptor-mediated inhibition of cAMP formation. Brain Res 2008;1207:111-119.
https://doi.org/10.1016/j.brainres.2008.02.025
PMid:18371938 PMCid:PMC2480521

 

4 Bardak H, Uguz AC, Bardak Y. Protective effects of melatonin and memantine in human retinal pigment epithelium (ARPE-19) cells against 2-ethylpyridine-induced oxidative stress: implications for age-related macular degeneration. Cutan Ocul Toxicol 2018;37(2):112-120.
https://doi.org/10.1080/15569527.2017.1354218
PMid:28707481

 

5 Berridge MJ. Calcium microdomains: organization and function. Cell Calcium 2006;40(5-6):405-412.
https://doi.org/10.1016/j.ceca.2006.09.002
PMid:17030366

 

6 Hajnóczky G, Csordás G. Calcium signalling: fishing out molecules of mitochondrial calcium transport. Curr Biol 2010;20(20): R888-R891.
https://doi.org/10.1016/j.cub.2010.09.035
PMid:20971432 PMCid:PMC3174682

 

7 Deisinger PJ, Hill TS, English JC. Human exposure to naturally occurring hydroquinone. J Toxicol Environ Health 1996;47(1):31-46.
https://doi.org/10.1080/009841096161915
PMid:8568910

 

8 Halliwell B. Oxidative stress and neurodegeneration: where are we now? J Neurochem 2006;97(6):1634-1658.
https://doi.org/10.1111/j.1471-4159.2006.03907.x
PMid:16805774

 

9 Nazıroglu M. Role of selenium on calcium signaling and oxidative stress-induced molecular pathways in epilepsy. Neurochem Res 2009;34(12):2181-2191.
https://doi.org/10.1007/s11064-009-0015-8
PMid:19513830

 

10 Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmeland LM. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res 1996;62(2):155-169.
https://doi.org/10.1006/exer.1996.0020
PMid:8698076

 

11 Uğuz AC, Naziroğlu M, Espino J, Bejarano I, González D, Rodríguez AB, Pariente JA. Selenium modulates oxidative stress-induced cell apoptosis in human myeloid HL-60 cells through regulation of calcium release and caspase-3 and -9 activities. J Membr Biol 2009;232(1-3):15-23.
https://doi.org/10.1007/s00232-009-9212-2
PMid:19898892

 

12 Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260(6):3440-3450.

 

13 Sharma A, Patil JA, Gramajo AL, Seigel GM, Kuppermann BD, Kenney CM. Effects of hydroquinone on retinal and vascular cells in vitro. Indian J Ophthalmol 2012;60(3):189-193.
https://doi.org/10.4103/0301-4738.95869
PMid:22569379 PMCid:PMC3361813

 

14 Altinkiliç S, Naziroğlu M, Uğuz AC, Ozcankaya R. Fish oil and antipsychotic drug risperidone modulate oxidative stress in PC12 cell membranes through regulation of cytosolic calcium ion release and antioxidant system. J Membr Biol 2010;235(3):211-218.
https://doi.org/10.1007/s00232-010-9267-0
PMid:20574816

 

15 Uguz AC, Cig B, Espino J, Bejarano I, Naziroglu M, Rodríguez AB, Pariente JA. Melatonin potentiates chemotherapy-induced cytotoxicity and apoptosis in rat pancreatic tumor cells. J Pineal Res 2012;53(1):91-98.
https://doi.org/10.1111/j.1600-079X.2012.00974.x
PMid:22288984

 

16 Placer ZA, Cushman LL, Johnson BC. Estimation of product of lipid peroxidation (malonyl dialdehyde) in biochemical systems. Anal Biochem 1966;16(2):359-364.
https://doi.org/10.1016/0003-2697(66)90167-9

 

17 Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1968;25(1):192-205.
https://doi.org/10.1016/0003-2697(68)90092-4

 

18 Lawrence RA, Burk RF. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun 1976;71(4):952-958.
https://doi.org/10.1016/0006-291X(76)90747-6

 

19 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193(1):265-275.

 

20 Igielska-Kalwat J, Gościańska J, Nowak I. Carotenoids as natural antioxidants. Postepy Hig Med Dosw (Online) 2015;69:418-428.
https://doi.org/10.5604/17322693.1148335

 

21 Uğuz AC, Nazıroğlu M. Effects of selenium on calcium signaling and apoptosis in rat dorsal root ganglion neurons induced by oxidative stress. Neurochem Res 2012;37(8):1631-1638.
https://doi.org/10.1007/s11064-012-0758-5
PMid:22476699

 

22 Liang FQ, Godley BF. Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration. Exp Eye Res 2003;76(4):397-403.
https://doi.org/10.1016/S0014-4835(03)00023-X

 

23 Chen C, Cano M, Wang JJ, Li JM, Huang CX, Yu Q, Herbert TP, Handa JT, Zhang SX. Role of unfolded protein response dysregulation in oxidative injury of retinal pigment epithelial cells. Antioxid Redox Signal 2014;20(14):2091-2106.
https://doi.org/10.1089/ars.2013.5240
PMid:24053669 PMCid:PMC3995121

 

24 Cai J, Nelson KC, Wu M, Sternberg P Jr, Jones DP. Oxidative damage and protection of the RPE. Prog Retin Eye Res 2000;19(2):205-221.
https://doi.org/10.1016/S1350-9462(99)00009-9

 

25 Mainster MA. Light and macular degeneration: a biophysical and clinical perspective. Eye (Lond) 1987;1(Pt 2):304-310.
https://doi.org/10.1038/eye.1987.49
PMid:3308530

 

26 Wu J, Seregard S, Spångberg B, Oskarsson M, Chen E. Blue light induced apoptosis in rat retina. Eye (Lond) 1999;13(Pt 4):577-583.
https://doi.org/10.1038/eye.1999.142
PMid:10692935

 

27 Otsuka T, Shimazawa M, Nakanishi T, Ohno Y, Inoue Y, Tsuruma K, Ishibashi T, Hara H. Protective effects of a dietary carotenoid, astaxanthin, against light-induced retinal damage. J Pharmacol Sci 2013;123(3):209-218.
https://doi.org/10.1254/jphs.13066FP

 

28 Song X, Wang B, Lin S, Jing L, Mao C, Xu P, Lv C, Liu W, Zuo J. Astaxanthin inhibits apoptosis in alveolar epithelial cells type II in vivo and in vitro through the ROS-dependent mitochondrial signalling pathway. J Cell Mol Med 2014;18(11):2198-2212.
https://doi.org/10.1111/jcmm.12347
PMid:25215580 PMCid:PMC4224554

 

29 Chen CS, Wu SH, Wu YY, Fang JM, Wu TH. Properties of astaxanthin/Ca2+ complex formation in the deceleration of cis/trans isomerization. Org Lett 2007;9(16):2985-2988.
https://doi.org/10.1021/ol0709533
PMid:17629283

 

30 Reijo T, Mikko B, Antti S, Timo S. Serum calcium and prediction of cognitive decline in old age. J Am Geriatr Soc 2008;56(8):1573-1574.
https://doi.org/10.1111/j.1532-5415.2008.01774.x
PMid:18808606

 

31 Kim CJ, Choi SK. Analysis of aqueous humor calcium and phosphate from cataract eyes with and without diabetes mellitus. Korean J Ophthalmol 2007;21(2):90-94.
https://doi.org/10.3341/kjo.2007.21.2.90
PMid:17592239 PMCid:PMC2629704

 

32 Sun G, Vasdev S, Martin GR, Gadag V, Zhang HW. Altered calcium homeostasis is correlated with abnormalities of fasting serum glucose, insulin resistance, and beta-cell function in the Newfoundland population. Diabetes 2005;54(11):3336-3339.
https://doi.org/10.2337/diabetes.54.11.3336
PMid:16249463

 

33 Giblin FJ. Glutathione: a vital lens antioxidant. J Ocul Pharmacol Ther 2000;16(2):121-135.
https://doi.org/10.1089/jop.2000.16.121
PMid:10803423

 

34 Li Z, Dong X, Liu H, Chen X, Shi H, Fan Y, Hou D, Zhang X. Astaxanthin protects ARPE-19 cells from oxidative stress via upregulation of Nrf2-regulated phase II enzymes through activation of PI3K/Akt. Mol Vis 2013;19:1656-1666.

 

35 Naguib YM. Antioxidant activities of astaxanthin and related carotenoids. J Agric Food Chem 2000;48(4):1150-1154.
https://doi.org/10.1021/jf991106k

 

36 Gammone MA, Riccioni G, D'Orazio N. Marine carotenoids against oxidative stress: effects on human health. Mar Drugs 2015;13(10):6226-6246.
https://doi.org/10.3390/md13106226
PMid:26437420 PMCid:PMC4626686

 

37 Wu J, Cho E, Willett WC, Sastry SM, Schaumberg DA. Intakes of lutein, zeaxanthin, and other carotenoids and age-related macular degeneration during 2 decades of prospective follow-up. JAMA Ophthalmol 2015;133(12):1415-1424.
https://doi.org/10.1001/jamaophthalmol.2015.3590
PMid:26447482 PMCid:PMC5119484

 

38 Rimessi A, Patergnani S, Bonora M, Wieckowski MR, Pinton P. Mitochondrial Ca2+ remodeling is a prime factor in oncogenic behavior. Front Oncol 2015;5:143.
https://doi.org/10.3389/fonc.2015.00143
PMid:26161362 PMCid:PMC4479728

 

39 Balietti M, Giannubilo SR, Giorgetti B, et al. The effect of astaxanthin on the aging rat brain: gender-related differences in modulating inflammation. J Sci Food Agric 2016;96(2):615-618.
https://doi.org/10.1002/jsfa.7131
PMid:25678261

 

40 Kowluru RA, Kowluru A, Mishra M, Kumar B. Oxidative stress and epigenetic modifications in the pathogenesis of diabetic retinopathy. Prog Retin Eye Res 2015;48:40-61.
https://doi.org/10.1016/j.preteyeres.2015.05.001
PMid:25975734

 

41 Piermarocchi S, Saviano S, Parisi V, Tedeschi M, Panozzo G, Scarpa G, Boschi G, Lo Giudice G, Carmis Study Group. Carotenoids in Age-related Maculopathy Italian Study (CARMIS): two-year results of a randomized study. Eur J Ophthalmol 2012;22(2):216-225.
https://doi.org/10.5301/ejo.5000069
PMid:22009916

 

42 Izumi-Nagai K, Nagai N, Ohgami K, Satofuka S, Ozawa Y, Tsubota K, Ohno S, Oike Y, Ishida S. Inhibition of choroidal neovascularization with an anti-inflammatory carotenoid astaxanthin. Invest Ophthalmol Vis Sci 2008;49(4):1679-1685.
https://doi.org/10.1167/iovs.07-1426
PMid:18385091

 

43 Nakajima Y, Inokuchi Y, Shimazawa M, Otsubo K, Ishibashi T, Hara H. Astaxanthin, a dietary carotenoid, protects retinal cells against oxidative stress in-vitro and in mice in-vivo. J Pharm Pharmacol 2008;60(10): 1365-1374.
https://doi.org/10.1211/jpp.60.10.0013